Merck (MRK), known as MSD outside of the United States and Canada, announced that the European Commission, or EC, has approved CAPVAXIVE, or ...

Three years after the start of the COVID-19 pandemic, coverage for selected routine childhood vaccines remained below ...

Merck & Co. has won approval from the European Commission of its Capvaxive pneumococcal disease vaccine for adults. The Rahway, N.J., drugmaker on Wednesday said the approval covers the 21-valent ...

In an attempt to strike a pitch-perfect tone with Generation X, Pfizer has recruited Elizabeth Banks as the face of a new ...

Two words come to mind for Elizabeth Banks after her showdown with shingles: "Not fun." ...

Gut microbiota may be the key factor explaining why certain individuals do not respond well to the pneumococcal vaccine, a ...

Patients' confidence in vaccines has waned since the COVID pandemic, according to a national poll and doctors.

Even if you received childhood vaccinations it’s important to consult a doctor to determine whether you need a booster shot ...

These vaccines include those for: COVID-19 the flu pneumococcal disease Tdap herpes zoster (shingles) If you have COPD, talk with a doctor about your current vaccinations. They can let you know ...

The Centers for Disease Control and Prevention has added a new vaccine recommendation for adults. Those as young as age 50 should get vaccinated against pneumococcal pneumonia, the CDC said. The ...

Researchers analyzed vaccine responses using genetically modified mouse models to study two types of pneumococcal vaccines-one commonly used in children and another in adults. Although these ...